<?xml version="1.0" encoding="UTF-8"?>
<ref id="B133-biomedicines-08-00060">
 <label>133.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Simon</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Harrer</surname>
    <given-names>D.C.</given-names>
   </name>
   <name>
    <surname>Thirion</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Schuler-Thurner</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Schuler</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Uslu</surname>
    <given-names>U.</given-names>
   </name>
  </person-group>
  <article-title>Enhancing lentiviral transduction to generate melanoma-specific human T cells for cancer immunotherapy</article-title>
  <source>J. Immunol. Methods</source>
  <year>2019</year>
  <volume>472</volume>
  <fpage>55</fpage>
  <lpage>64</lpage>
  <pub-id pub-id-type="doi">10.1016/j.jim.2019.06.015</pub-id>
  <pub-id pub-id-type="pmid">31207210</pub-id>
 </element-citation>
</ref>
